Investor Relations

Latest Financial Results

Q2 2023

Quarter Ended Jun 30, 2023

Latest Annual Filing

Fiscal Year Ended Dec 31, 2022

View Filing

Stock Information

Company Overview

Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders.

Download Corporate Presentation

Investor Contact Information


Ocuphire Pharma, Inc.
37000 Grand River Ave., Suite 120
Farmington Hills, MI 48335
T: 248-957-9024
[email protected]

Investor Relations

LifeSci Advisors
250 West 55th Street, Suite 3401
New York, NY 10019
T: 646-889-1200
[email protected]

377 Oak Street, Level 2
Garden City, New York 11530
T: 212-655-0924
[email protected]

Transfer Agent

American Stock Transfer & Trust Company LLC
6201 15th Avenue
Brooklyn, NY 11219
T: 800-937-5449